Kyowa Kirin Co., Ltd. (4151.T)

JPY 2168.0

(0.91%)

Revenue Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual revenue in 2023 was 442.23 Billion JPY , up 11.01% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 129.82 Billion JPY , up 1.9% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported a annual revenue of 398.37 Billion JPY in annual revenue 2022, up 13.09% from previous year.
  • Kyowa Kirin Co., Ltd. reported a annual revenue of 352.24 Billion JPY in annual revenue 2021, up 10.65% from previous year.
  • Kyowa Kirin Co., Ltd. reported a quarterly revenue of 105.56 Billion JPY for 2024 Q1, down -22.48% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported a quarterly revenue of 127.4 Billion JPY for 2024 Q2, up 20.68% from previous quarter.

Annual Revenue Chart of Kyowa Kirin Co., Ltd. (2023 - 1999)

Historical Annual Revenue of Kyowa Kirin Co., Ltd. (2023 - 1999)

Year Revenue Revenue Growth
2023 442.23 Billion JPY 11.01%
2022 398.37 Billion JPY 13.09%
2021 352.24 Billion JPY 10.65%
2020 318.35 Billion JPY 4.1%
2019 305.82 Billion JPY -11.75%
2018 346.53 Billion JPY -1.94%
2017 353.38 Billion JPY 3.02%
2016 343.01 Billion JPY -5.85%
2015 364.31 Billion JPY 9.26%
2014 333.44 Billion JPY -2.1%
2013 340.61 Billion JPY 2.24%
2012 333.15 Billion JPY -3.07%
2011 343.72 Billion JPY -16.92%
2010 413.73 Billion JPY 0.0%
2009 - JPY -100.0%
2008 460.18 Billion JPY 17.36%
2007 392.12 Billion JPY 10.68%
2006 354.27 Billion JPY 0.24%
2005 353.44 Billion JPY -1.54%
2004 358.96 Billion JPY 2.9%
2003 348.83 Billion JPY -2.91%
2002 359.28 Billion JPY -5.12%
2001 378.66 Billion JPY 0.81%
2000 375.61 Billion JPY 0.19%
1999 374.91 Billion JPY 0.0%

Peer Revenue Comparison of Kyowa Kirin Co., Ltd.

Name Revenue Revenue Difference
Astellas Pharma Inc. 1603.67 Billion JPY 72.424%
Chugai Pharmaceutical Co., Ltd. 1111.36 Billion JPY 60.208%
Ono Pharmaceutical Co., Ltd. 502.67 Billion JPY 12.024%
Santen Pharmaceutical Co., Ltd. 301.96 Billion JPY -46.452%
JCR Pharmaceuticals Co., Ltd. 42.87 Billion JPY -931.543%
Daiichi Sankyo Company, Limited 1601.68 Billion JPY 72.39%
Otsuka Holdings Co., Ltd. 2018.56 Billion JPY 78.092%
Perseus Proteomics Inc. 100.4 Million JPY -440362.341%